Takeda Pharmaceutical Co.’s 2019 acquisition of its larger European rival Shire PLC made it one of the most indebted drugmakers in the world. Four years later, Takeda has not only brought its debt ...
Consumers have grown used to being told to give up their brand-name drugs in favor of cheaper generics. Now some are finding the opposite is true. By Charles Ornstein and Katie Thomas When ...
The pharmaceutical company behind Martin Shkreli’s infamous 4,000 percent price hike—now known as Vyera Pharmaceuticals—filed for bankruptcy this week and plans to sell its assets to pay off millions ...
Plattsburgh officials say business development remains strong despite the announcement this week that a pharmaceutical company will close its manufacturing facility in October. SterRx manufactures ...
(Reuters) - Pharmaceutical company Shire Plc said it had bought New York-based Foresight Biotherapeutics Inc for $300 million in cash, gaining access to a late-stage therapy being developed for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback